Trial Profile
The Comparison of Treatment Sequence of Parallel rTMS and Rehabilitation and Rehabilitation Only
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Aphasia; Paresis
- Focus Adverse reactions; Therapeutic Use
- 12 Nov 2021 Planned number of patients changed from 20 to 50.
- 06 Oct 2018 Status changed from recruiting to completed.
- 30 May 2016 New trial record